Lam Research Corporation LRCX NDXSPXAI
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits in the United States, China, Korea, Taiwan, Japan, Southeast Asia, and Europe. The company offers ALTUS systems to deposit conformal or selective films for tungsten or molybdenum metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SPEED gapfill high-density plasma chemical vapor deposition (CVD) products; Striker single-wafer atomic layer deposition products for dielectric film solutions; and VECTOR plasma-enhanced CVD products. It also provides Flex for dielectric etch applications; Vantex, a dielectric etch system that provides RF technology and repeatable wafer-to-wafer performance enabled by Equipment Intelligence solutions; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. In addition, the company offers Coronus bevel clean products to enhance die yield; and Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications. Further, it provides Reliant deposition, etch, and clean products; and Sense.i platform products, as well as customer service, spares, and upgrades. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Strong return on equity of 66.8%.
- Healthy ROCE of 41.5%.
- Excellent profit margin of 30.9%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 60.3.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LRCX Lam Research Corporation NDXSPXAI | 318.18 | 60.26 | $397.91B | 0.33% | 41.53% | 66.76% | 2.29% | 5.18% |
| 2 | NVDA NVIDIA Corporation NDXSPXAI | 211.14 | 32.38 | $5.11T | 0.47% | 81.14% | 114.29% | 100.05% | 201.80% |
| 3 | AAPL Apple Inc. NDXSPX | 312.06 | 37.73 | $4.58T | 0.35% | 68.72% | 141.47% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXAI | 450.24 | 26.82 | $3.34T | 0.81% | 26.37% | 34.01% | 12.42% | 11.87% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AI | 418.45 | 35.86 | $2.17T | 0.91% | 32.04% | 36.21% | 18.94% | 19.57% |
| 6 | MU Micron Technology, Inc. NDXSPXAI | 971.00 | 45.87 | $1.10T | 0.06% | 14.20% | 39.82% | 6.71% | -0.57% |
| 7 | AMD Advanced Micro Devices, Inc. NDXSPXAI | 516.10 | 172.61 | $841.55B | - | 6.33% | 8.06% | 13.64% | 48.64% |
| 8 | ORCL Oracle Corporation SPXAI | 225.78 | 40.46 | $649.35B | 0.89% | 13.07% | 57.57% | 10.59% | 22.81% |
| 9 | ASML ASML Holding N.V. NDXAI | 1,612.76 | 53.76 | $621.59B | 0.54% | 43.81% | 52.24% | 15.55% | 19.55% |
Quarterly Results
Figures in USD.
| Metric | Sep 2013 | Dec 2013 | Mar 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 2.48B | 2.58B | 2.89B | 2.33B | 2.52B | 2.44B | 2.17B | 2.58B | 2.50B | 3.18B | 3.46B | 3.85B | 4.30B | 4.23B | 4.06B | 5.07B | 5.28B | 3.87B | 3.48B | 3.76B | 3.79B | - | - | 4.72B | 5.17B | 5.32B | 5.34B | 5.84B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.41B | 2.58B | 2.64B | 2.69B | 2.93B |
| Gross Profit | 431.86M | 487.79M | 530.80M | 505.54M | 536.66M | 600.60M | 722.36M | 626.51M | 571.26M | 716.20M | 846.80M | 971.40M | 1.15B | 1.21B | 1.33B | 1.06B | 1.15B | 1.07B | 981.71M | 1.18B | 1.17B | 1.51B | 1.60B | 1.78B | 1.98B | 1.98B | 1.82B | 2.34B | 2.38B | 1.61B | 1.65B | 1.76B | 1.80B | - | - | 2.31B | 2.59B | 2.68B | 2.65B | 2.91B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 751.93M | 848.58M | 855.79M | 840.96M | 863.51M |
| Operating Income | 105.41M | 164.47M | 191.94M | 168.30M | 188.74M | 239.97M | 335.43M | 238.83M | 190.75M | 315.95M | 439.83M | 538.42M | 693.22M | 737.37M | 827.51M | 591.75M | 690.38M | 565.52M | 537.46M | 686.51M | 694.11M | 961.06M | 1.01B | 1.20B | 1.37B | 1.34B | 1.19B | 1.70B | 1.68B | 942.25M | 1.02B | 1.06B | 1.06B | - | - | 1.56B | 1.74B | 1.83B | 1.81B | 2.05B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.68B | 1.92B | 2.00B | 1.98B | 2.17B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 45.18M | 42.77M | 42.47M | 40.88M | 39.33M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.54B | 1.78B | 1.86B | 1.84B | 2.01B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 206.06M | 58.89M | 290.50M | 242.62M | 186.10M |
| Net Income | 85.51M | 148.99M | 164.40M | 141.08M | 176.94M | 206.28M | 288.68M | 222.98M | 143.45M | 263.83M | 332.79M | 574.71M | 590.69M | -9.96M | 778.80M | 533.36M | 568.86M | 547.39M | 465.79M | 514.51M | 574.78M | 823.45M | 869.23M | 1.07B | 1.18B | 1.19B | 1.02B | 1.43B | 1.47B | 814.01M | 887.40M | 954.27M | 965.83M | - | - | 1.33B | 1.72B | 1.57B | 1.59B | 1.83B |
| Diluted EPS | 0.50 | 0.87 | 0.96 | 0.80 | 1.00 | 1.16 | 1.66 | 1.28 | 0.82 | 1.47 | 1.81 | 3.10 | 3.21 | -0.06 | 4.33 | 3.23 | 3.51 | 3.47 | 3.09 | 3.43 | 3.88 | 5.59 | 5.96 | 7.41 | 8.27 | 8.44 | 7.30 | 10.39 | 10.77 | 6.01 | 0.67 | 0.72 | 0.73 | - | - | 1.03 | 1.35 | 1.24 | 1.26 | 1.45 |
| R&D Expense | 170.57M | 174.48M | 185.98M | 188.93M | 196.77M | 217.87M | 234.21M | 220.75M | 221.49M | 235.24M | 246.80M | 265.99M | 275.08M | 281.31M | 305.41M | 291.67M | 285.56M | 318.51M | 286.83M | 318.86M | 307.91M | 355.37M | 375.17M | 381.12M | 382.33M | 403.64M | 407.12M | 433.38M | 462.38M | 429.45M | 422.63M | 469.71M | 512.27M | 495.36M | 494.95M | 525.90M | - | 576.45M | 573.30M | 583.20M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | 8.01B | 11.08B | 9.65B | 10.04B | 14.63B | 17.23B | 17.43B | 14.91B | 18.44B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.36B | 9.65B | 7.85B | 9.46B |
| Gross Profit | 388.73M | 969.93M | 1.50B | 1.08B | 1.40B | 2.01B | 2.28B | 2.62B | 3.60B | 5.17B | 4.36B | 4.61B | 6.81B | 7.87B | 7.78B | 7.05B | 8.98B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.49B | 2.56B | 2.77B | 3.08B |
| Operating Income | -281.24M | 425.41M | 804.28M | 237.73M | 118.07M | 677.67M | 788.04M | 1.07B | 1.90B | 3.21B | 2.46B | 2.67B | 4.48B | 5.38B | 5.22B | 4.28B | 5.90B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.71B | 5.64B | 4.91B | 6.52B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | 184.76M | 186.46M | 185.24M | 178.20M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.19B | 5.11B | 4.36B | 5.96B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | 587.83M | 598.28M | 532.45M | 599.91M |
| Net Income | -302.15M | 346.67M | 723.75M | 168.72M | 113.88M | 632.29M | 655.58M | 914.05M | 1.70B | 2.38B | 2.19B | 2.25B | 3.91B | 4.61B | 4.51B | 3.83B | 5.36B |
| Diluted EPS | -2.41 | 2.71 | 5.79 | 1.35 | 0.66 | 3.62 | 3.70 | 5.22 | 9.24 | 13.17 | 13.70 | 15.10 | 26.90 | 3.27 | 3.32 | 2.90 | 4.15 |
| R&D Expense | 288.27M | 320.86M | 373.29M | 444.56M | 683.69M | 716.47M | 825.24M | 913.71M | 1.03B | 1.19B | 1.19B | 1.25B | 1.49B | 1.60B | 1.73B | 1.90B | 2.10B |
Compounded Sales Growth
| 5 Years: | 2.29% |
| 1 Year: | 23.80% |
Compounded Profit Growth
| 5 Years: | 5.18% |
| 1 Year: | 40.80% |
Stock Price Performance
| 1 Year: | +296.72% |
| 6 Months: | +110.02% |
| 3 Months: | +36.20% |
| 1 Month: | +27.91% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2008 | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 2.49B | 4.05B | 8.00B | 7.25B | 7.99B | 9.36B | 12.26B | 12.12B | 12.48B | 12.00B | 14.56B | - | 17.20B | 18.78B | 18.74B | 21.35B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12.29B | 13.23B | 12.88B | 14.52B |
| Cash & Equivalents | 732.54M | 374.17M | 545.77M | 1.49B | 1.56B | 1.16B | 1.45B | 1.50B | 5.04B | 2.38B | 4.51B | 3.66B | 4.92B | - | 3.52B | 5.34B | 5.85B | 6.39B |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.97B | 4.82B | 4.22B | 4.31B |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.31B | 2.82B | 2.52B | 3.38B |
| Total Liabilities | - | - | 719.26M | 1.58B | 2.68B | 2.57B | 2.78B | 4.02B | 6.16B | 5.14B | 5.90B | 7.28B | 9.38B | - | 10.92B | 10.57B | 10.21B | 11.48B |
| Current Liabilities | - | - | 558.66M | 680.76M | 1.43B | 1.40B | 1.58B | 2.63B | 2.42B | 2.95B | 3.15B | 2.37B | 3.16B | - | 4.56B | 4.18B | 4.34B | 6.57B |
| Long Term Debt | - | - | - | 900.66M | 749.30M | 777.40M | 806.90M | 993.96M | 3.38B | 1.78B | 1.76B | 3.77B | 4.96B | - | 4.96B | 4.96B | 4.47B | 3.72B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.01B | 5.01B | 4.98B | 4.48B |
| Total Equity | 1.78B | 1.45B | 1.77B | 2.47B | 5.13B | 4.49B | 5.03B | 5.10B | 5.89B | 6.82B | 6.50B | 4.67B | 5.17B | - | 6.28B | 8.21B | 8.54B | 9.86B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.94B | 2.95B | 2.95B | 2.96B |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -78.13M | 350.71M | 881.03M | 499.03M | 719.93M | - | - | - | 2.03B | 2.66B | 3.18B | 2.13B | - | 3.10B | 5.18B | 4.65B | 6.17B |
| Investing Cash Flow | 6.00M | -103.36M | -479.91M | 269.73M | -238.64M | - | - | - | -2.05B | 2.75B | -1.64B | -244.08M | - | 612.27M | -534.56M | -370.61M | -708.09M |
| Financing Cash Flow | -260.83M | -72.66M | 526.99M | -692.75M | -887.79M | - | - | - | -2.63B | -3.27B | -2.39B | -623.93M | - | -4.58B | -2.83B | -4.00B | -4.94B |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | - | - | - | -546.03M | -501.57M | -396.67M | -759.19M |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.55B | 4.68B | 4.26B | 5.41B |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | -866.99M | 1.81B | 285.81M | 528.53M |
| Share Buybacks | 30.95M | 93.03M | 211.32M | 772.66M | 955.66M | 244.86M | 573.24M | 158.39M | 811.67M | 2.65B | 3.78B | 1.37B | 2.70B | 3.87B | 2.02B | 2.84B | 3.42B |
| Dividends Paid | - | - | - | - | - | 0 | 116.06M | 190.40M | 243.50M | 307.61M | 678.35M | 656.84M | 726.99M | 815.29M | 907.91M | 1.02B | 1.15B |
Ratios (Annual)
Figures in %.
| Metric | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | 45.0% | 46.6% | 45.1% | 45.9% | 46.5% | 45.7% | 44.6% | 47.3% | 48.7% |
| Operating Margin % | - | - | - | - | - | - | - | - | 23.7% | 29.0% | 25.5% | 26.6% | 30.6% | 31.2% | 29.9% | 28.7% | 32.0% |
| Net Margin % | - | - | - | - | - | - | - | - | 21.2% | 21.5% | 22.7% | 22.4% | 26.7% | 26.7% | 25.9% | 25.7% | 29.1% |
| ROE % | -20.8% | 19.6% | 29.3% | 3.3% | 2.5% | 12.6% | 12.8% | 15.5% | 24.9% | 36.6% | 46.9% | 43.5% | - | 73.4% | 54.9% | 44.8% | 54.3% |
| ROCE % | - | 22.1% | 23.8% | 3.6% | 2.0% | 10.6% | 11.7% | 10.9% | 20.7% | 34.4% | 25.6% | 23.5% | - | 42.6% | 35.7% | 29.7% | 39.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 10.62% | 132.85M | $42.27B |
| 2 | Vanguard Capital Management LLC | 6.49% | 81.16M | $25.82B |
| 3 | State Street Corporation | 4.73% | 59.16M | $18.82B |
| 4 | Vanguard Portfolio Management LLC | 2.96% | 37.06M | $11.79B |
| 5 | Geode Capital Management, LLC | 2.81% | 35.18M | $11.19B |
| 6 | FMR, LLC | 2.68% | 33.57M | $10.68B |
| 7 | JPMORGAN CHASE & CO | 2.62% | 32.71M | $10.41B |
| 8 | Invesco Ltd. | 1.94% | 24.26M | $7.72B |
| 9 | Ameriprise Financial, Inc. | 1.66% | 20.79M | $6.61B |
| 10 | Morgan Stanley | 1.52% | 18.97M | $6.04B |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for LRCX